Glp 1 Medications
-
{
- All
- News
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
- Wednesday May 6, 2026
- Health | Written by Sambhav Kumar
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
www.ndtv.com
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
- Sunday May 3, 2026
- Health | Written by Debosmita Ghosh
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
www.ndtv.com
-
New Study Explains Why Ozempic Doesn't Work For Everyone
- Monday April 13, 2026
- Health | Written by Rupashi Chhabra
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
- Wednesday May 6, 2026
- Health | Written by Sambhav Kumar
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
www.ndtv.com
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
- Sunday May 3, 2026
- Health | Written by Debosmita Ghosh
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
www.ndtv.com
-
New Study Explains Why Ozempic Doesn't Work For Everyone
- Monday April 13, 2026
- Health | Written by Rupashi Chhabra
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com